Monday, June 6, 2016

Interview with Dr. Kipps on CLL(chronic lymphocytic leukemia) research from ASH 2015

Well, my bags are finally packed. Better be! I am at the airport ready to go to the European Hematology Association meeting in Copenhagen. 

Before the meeting starts on Thursday, I’ll be presenting some preliminary data from our Reader Poll at a symposium on Wednesday and attending a couple of other meetings with global Lymphoma groups. I have numerous other meetings and interviews set up and I’m hoping to get a little bit of time outside the convention center to at least see The Little Mermaid statue.

This week in the Conference Coverage section of the CLL Society website, we’ve posted a rambling interview with Dr. Thomas Kipps from ASH 2015. We discussed the latest data in the fight to defeat CLL using signal blockers, Venetoclax, ROR1 antibodies as well as the importance of more research. You can read a summary of our discussion and watch my interview with Dr. Kipps here. http://cllsociety.org/2016/06/dr-kipps-signal-blockers-venetoclax-ror1-antibodies-importance-research/  

From time to time, we will make you aware of in-person meetings coming up for those of us affected by CLL. In June, they include:

June 16th at 6 PM in Salt Lake City, UT: The Lymphoma Research Foundation will be hosting Updates on Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma as part of their Ask the Doctor series. You can find out more information and register here. http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=9384957 

There is no charge to attend.
In the meantime….
Stay strong.

We are all in this together.

Brian Koffman, MD
Volunteer Medical Director of the CLL Society

Labels: , , , ,

2 Comments:

Blogger aliya seen said...

The best way to research symptoms are to write nephrology fellowship personal statement for the the latest data in the fight to defeat CLL using signal blockers, Venetoclax. This is great in use for them.

June 13, 2016 at 8:15 AM  
Blogger Allen jeley said...

nice post

November 24, 2016 at 11:27 PM  

Post a Comment

Subscribe to Post Comments [Atom]

<< Home